NDC 51031-025-25 - RE-COVR

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51031-025
Requested NDC: 51031-025-25
Package NDCs from labels: 51031-025-25
Manufacturer: Kinetic Technologies, LLC
Effective date: 2022-02-24
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
RE-COVR - Kinetic Technologies, LLC	Kinetic Technologies, LLC	2022-02-24	PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51031-025-25	RE-COVR	250 mL in 1 BOTTLE, GLASS	INJECTION	250		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51031-025	RE-COVR (TRIPELENNAMINE HYDROCHLORIDE) INJECTION [KINETIC TECHNOLOGIES, LLC]	2	1 package rows	20220225_2010c3e9-a34e-421c-b436-821245aecb6e.zip

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.